top of page
  • Website
  • Facebook
  • Twitter
  • Fundraising
  • LinkedIn

GABRA1

Symptoms which have been reported by some individuals or publications associated with this gene (some individuals may experience more than one, or none of these symptoms):

  • Epilepsy

  • Developmental delay

  • Intellectual disability

  • Dravet syndrome

  • West syndrome

  • Lennox-Gastaut syndrome

  • Autism

  • Hypotonia

  • Choreoathetoid movement

Patient-derived iPS cell lines (in progress):

 

GABRA1:  c.869_888del, p.Val290fs (plus isogenic control)

 

 

 

 

Publications:

GABRA1‐related disorders: from genetic to functional pathways - Musto - Annals of Neurology - Wiley Online Library

Pharmacological chaperones restore proteostasis of epilepsy-associated GABAA receptor variants

Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors

 

Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABAA receptors

 

Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies

 

Remodeling the endoplasmic reticulum proteostasis network restores proteostasis of pathogenic GABAA receptors

 

Differential Coassembly of α1-GABAARs Associated with Epileptic Encephalopathy

 

Successful use of perampanel in GABRA1-related myoclonic epilepsy with photosensitivity

 

GABAA Receptor Variants in Epilepsy

 

Clinical phenotypes of epilepsy associated with GABRA1 gene variants

 

A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro

 

Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy

 

Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): A cohort study, review of literature, and genotype-phenotype correlation

 

GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients

 

SAHA enhances Proteostasis of epilepsy-associated α1(A322D)β2γ2 GABA(A) receptors

 

Combining valosin-containing protein (VCP) inhibition and suberanilohydroxamic acid (SAHA) treatment additively enhances the folding, trafficking, and function of epilepsy-associated γ-aminobutyric acid, type A (GABAA) receptors

 

Proteostasis regulators restore function of epilepsy-associated GABAA receptors

 

L-type Calcium Channel Blockers Enhance Trafficking and Function of Epilepsy-associated α1(D219N) Subunits of GABA(A) Receptors

Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human - PubMed (nih.gov)

Info@gabaa.org

EIN: 92-3923437

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
candid-seal-bronze-2025.png

GABA-A Alliance is a 501(c)3 tax-exempt organization and your donation is tax-deductible within the guidelines of U.S. law.  Please keep your email donation receipt as your official record. We’ll send it to you upon successful completion of your donation.

bottom of page